Vaccine trial as "probe" to define the burden of pneumococcal pneumonia disease.
| Publicado en: | Lancet Vol. 365; no. 9465; pp. 1113 - 1115 |
|---|---|
| Autores principales: | , , , |
| Formato: | commentary Journal Article |
| Publicado: |
Lancet
3/26/2005
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106551554&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106551554 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 3/26/2005 vid: 365 iid: 9465 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 106551554 106551554 NLM15794951 2009065007 10.1016/s0140-6736(05)71853-5 NLM15794951 106551554 ppf: 1113 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Vaccine trial as "probe" to define the burden of pneumococcal pneumonia disease. aug: au: Lucero MG Williams G Lucero, Marilla G Williams, Gail affil: Research Institute for Tropical Medicine, Filinvest Corporate City 1770, Alabang, MetroManila, Philippines sug: subj: Pneumococcal Vaccine Administration and Dosage Pneumonia, Bacterial Prevention and Control Clinical Trials Gambia Infant Pneumonia, Bacterial Epidemiology Infant: 1-23 months pubtype: Academic Journal doctype: commentary Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|